Preparation of ~(188)Re-NEPTDD and its biodistribution
Wei Hongyuan
Abstract
Wei Hongyuan
Abstract
On the basis of first synthesizing NEPTDD (2,2,9,9-tetramethyl-4,7-diaza-4-piperidinyl-ethyl- 1,10-decanedithiol), 188 Re-NEPTDD was prepared with SnCl2 as the reducing agent. The biodistribution of 188Re-NEPTDD injected through the tail vein into normal mice and that of lipiodol solution of 188Re-NEPTDD injected through the hepatic arteries into rabbits were studied, and the whole body imaging of rabbit after injecting the lipiodol solution was performed. The results showed that liver uptake of 188Re-NEPTDD was the highest and uptakes in other organs were relatively lower.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
On the basis of first synthesizing NEPTDD (2,2,9,9-tetramethyl-4,7-diaza-4-piperidinyl-ethyl- 1,10-decanedithiol), 188 Re-NEPTDD was prepared with SnCl2 as the reducing agent. The biodistribution of 188Re-NEPTDD injected through the tail vein into normal mice and that of lipiodol solution of 188Re-NEPTDD injected through the hepatic arteries into rabbits were studied, and the whole body imaging of rabbit after injecting the lipiodol solution was performed. The results showed that liver uptake of 188Re-NEPTDD was the highest and uptakes in other organs were relatively lower.
Key concepts: Lipiodol, Biodistribution, Nuclear medicine, Radiochemistry, Chemistry, Tail vein, Vein, Embolization